Fractyl Health, Inc
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches for the treatment of metabolic diseases, including type 2 diabetes and obesity. Our goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of T2D and obesity. We believe there is significant clinical and economic opportunity for new approaches to achieve a major leap forward with new disease-modifying strategies that are designed to target and potentially reverse root cause pathology of these diseases. We have assembled a mission-driven team of innovators and experts in the root causes of metabolic disease, all united in their passion to develop breakthrough therapies—the type of therapies we would want for ourselves, our family members, and our loved ones with these diseases.
